4.8 Medium
CVSS3
Attack Vector
ADJACENT
Attack Complexity
HIGH
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
NONE
Integrity Impact
HIGH
Availability Impact
NONE
CVSS:3.1/AV:A/AC:H/PR:L/UI:N/S:U/C:N/I:H/A:N
0.0004 Low
EPSS
Percentile
10.4%
Successful exploitation of this vulnerability could allow an unauthorized user to deliver too much or too little insulin through delivery of an unintended insulin bolus or because insulin delivery is slowed or stopped.
The following versions of the Medtronic NGP 600 Series Insulin Pumps and accessory components are affected:
A vulnerability exists which could allow an unauthorized user to learn aspects of the communication protocol used to pair system components while the pump is being paired with other system components. Exploitation requires nearby wireless signal proximity with the patient and the device; advanced technical knowledge is required for exploitation.
CVE-2022-32537 has been assigned to this vulnerability. A CVSS v3 base score of 4.8 has been calculated; the CVSS vector string is (AV:A/AC:H/PR:L/UI:N/S:U/C:N/I:H/A:N).
Medtronic internally identified and reported this vulnerability to CISA.
Medtronic recommends users to take the following actions:
Note: Turning off the remote bolus feature will ensure no remote bolus is possible.
Medtronic has identified the following precautions to assist users:
CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.
CISA also provides a section for control systems security recommended practices on the ICS webpage at cisa.gov/ics. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov/ics in the technical information paper, ICS-TIP-12-146-01B–Targeted Cyber Intrusion Detection and Mitigation Strategies.
Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents.
No known public exploits specifically target this vulnerability. This vulnerability has a high attack complexity.
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2022-32537
cisa.gov/ics
cisa.gov/ics
cwe.mitre.org/data/definitions/693.html
public.govdelivery.com/accounts/USDHSCISA/subscriber/new?topic_id=USDHSCISA_138
twitter.com/CISAgov
twitter.com/intent/tweet?text=Medtronic%20NGP%20600%20Series%20Insulin%20Pumps+https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-263-01
us-cert.cisa.gov/ics/Recommended-Practices
us-cert.cisa.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf
www.cisa.gov/uscert/ics/tips/ICS-TIP-12-146-01B
www.dhs.gov
www.dhs.gov/foia
www.dhs.gov/performance-financial-reports
www.facebook.com/CISA
www.facebook.com/sharer/sharer.php?u=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-263-01&title=Medtronic%20NGP%20600%20Series%20Insulin%20Pumps
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:H/PR:L/UI:N/S:U/C:N/I:H/A:N
www.instagram.com/cisagov
www.linkedin.com/company/cybersecurity-and-infrastructure-security-agency
www.linkedin.com/sharing/share-offsite/?url=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-263-01
www.oig.dhs.gov/
www.surveymonkey.com/r/CISA-cyber-survey?product=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-263-01
www.usa.gov/
www.whitehouse.gov/
www.youtube.com/@cisagov
mailto:?subject=Medtronic%20NGP%20600%20Series%20Insulin%20Pumps&body=www.cisa.gov/news-events/ics-medical-advisories/icsma-22-263-01